PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Traditional and novel virologic markers for functional cure and HBeAg loss with pegylated interferon in chronic hepatitis B

2026-01-29
(Press-News.org) Background and Aims The rate of functional cure (HBsAg loss) remains unsatisfactory following pegylated interferon (PEG-IFN) treatment in chronic hepatitis B. To optimize PEG-IFN administration, this study aimed to evaluate virological markers to predict functional cure and/or hepatitis B e antigen (HBeAg) loss.

Methods Relevant studies assessing virologic markers for predicting functional cure and HBeAg loss after PEG-IFN therapy were systematically retrieved from PubMed, Embase, the Cochrane Library, and Web of Science up to November 2023. Predictive effectiveness was evaluated via the summary receiver operating characteristic curve.

Results We analyzed 38 studies (6,179 patients). HBsAg decline at week 24 had the greatest discriminative ability according to the area under the receiver operating characteristic curve (AUROC) (0.89) and sensitivity (0.88) for predicting functional cure, whereas baseline HBsAg had a comparable AUROC (0.86) and highest specificity (0.79), with both being significantly better than baseline hepatitis B core-related antigen and hepatitis B virus (HBV) RNA (all P < 0.001). For HBeAg loss or seroconversion, HBV RNA, HBV DNA, HBeAg, and HBeAg decline at week 12, as well as HBV DNA and HBeAg decline at week 24, all exhibited comparable predictive values (AUROC = 0.75–0.78). HBV RNA and HBeAg levels at week 24 showed optimal sensitivity (0.87), and HBeAg decline at week 12 had the highest specificity (0.83).

Conclusions HBsAg decline at week 24 and baseline HBsAg levels are better predictors of functional cure than novel virologic markers, while on-treatment HBV RNA and HBeAg levels and dynamic changes are the most reliable indicators for HBeAg loss.

 

Full text

https://www.xiahepublishing.com/2310-8819/JCTH-2025-00443

 

The study was recently published in the Journal of Clinical and Translational Hepatology.

The Journal of Clinical and Translational Hepatology (JCTH) is owned by the Second Affiliated Hospital of Chongqing Medical University and published by XIA & HE Publishing Inc. JCTH publishes high quality, peer reviewed studies in the translational and clinical human health sciences of liver diseases. JCTH has established high standards for publication of original research, which are characterized by a study’s novelty, quality, and ethical conduct in the scientific process as well as in the communication of the research findings. Each issue includes articles by leading authorities on topics in hepatology that are germane to the most current challenges in the field. Special features include reports on the latest advances in drug development and technology that are relevant to liver diseases. Regular features of JCTH also include editorials, correspondences and invited commentaries on rapidly progressing areas in hepatology. All articles published by JCTH, both solicited and unsolicited, must pass our rigorous peer review process.

Follow us on X: @xiahepublishing

Follow us on LinkedIn: Xia & He Publishing Inc.

END



ELSE PRESS RELEASES FROM THIS DATE:

Novel quantum refrigerator benefits from problematic noise

2026-01-29
For quantum computers to function, they must be kept at extremely low temperatures. However, today’s cooling systems also generate noise that interferes with the fragile quantum information they are meant to protect. Now, researchers at Chalmers University of Technology in Sweden have developed an entirely new type of minimal quantum "refrigerator", which is partly driven by the noise itself. This refrigerator enables very precise control over heat and energy flows and could ...

AI tools help decode how TCM formulas work

2026-01-29
Traditional Chinese medicine formulas (TCMFs) are widely used in clinical practice, but their molecular mechanisms can be difficult to pin down because formulas often contain many constituents that act on multiple targets and pathways. In a new review in the Chinese Journal of Natural Medicines, researchers describe how artificial intelligence (AI) methods are increasingly being used to tackle this complexity and accelerate mechanism-oriented research on TCMFs.   The review, authored by researchers ...

Rethinking ultrasound gel: a natural solid pad for clearer, more comfortable imaging

2026-01-29
Ultrasonography is a non-invasive imaging technique used for real-time imaging. This versatile technique is used as a reliable diagnostic tool in various modalities. The conventional liquid gel used in ultrasonography is a critical component of this process that acts as an acoustic coupling medium, removing the air gap between the probe and skin surface. This allows improved image resolution and accurate diagnostic interpretations. However, the liquid gel has a quick drying time, which often compromises the image quality. Additionally, it may irritate patients and occasionally become contaminated. The clinician's performance is ...

Research from IOCB Prague reveals a previously unknown mechanism of genetic transcription

2026-01-29
Scientists at IOCB Prague are uncovering new details of gene transcription. They have identified a previously unknown molecular mechanism by which the transcription of genetic information from deoxyribonucleic acid (DNA) into ribonucleic acid (RNA) can be initiated. The researchers focused on a specific class of molecules known as alarmones, which are found in cells across a wide range of organisms and whose levels often increase under conditions of cellular stress. The results were published in the prestigious ...

Stimulating the brain with electromagnetic therapy after stroke may help reduce disability

2026-01-29
Research Highlights: Electromagnetic network-targeted field (ENTF) therapy, which targets specific connections in the brain, combined with physical therapy, significantly reduced disability in stroke survivors after 90 days. An analysis of two small clinical trials suggests that ENTF therapy is safe and works well in reducing overall disability after stroke. Note: The study featured in this news release is a research abstract. Abstracts presented at the American Heart Association/American Stroke Association’s scientific meetings are not peer-reviewed, and the findings are considered preliminary until published as a full ...

Women with stroke history twice as likely to have another during or soon after pregnancy

2026-01-29
Research Highlights: Female stroke survivors were more than twice as likely as their stroke-free counterparts to have another stroke while pregnant and in the six weeks after childbirth, according to an analysis of a large national database of electronic health records. In addition, the risk of ischemic stroke during pregnancy and the early postpartum period was 82% more likely among pregnant women who had a previous heart attack and 25% more likely in women with obesity. Note: The study featured in this news release is a research abstract. Abstracts presented at the American Heart Association/American Stroke Association’s ...

Older adults’ driving habits offer window into brain health, cognitive decline

2026-01-29
Research Highlights: A study of over 200 adults followed for five years found that greater white matter damage in the brain was linked to decreased driving, fewer trips, repetitive routes and having more driving errors, especially in those who later developed dementia. In contrast, adults ages 65 and older who were taking blood pressure medicines, particularly ACE inhibitors, were less likely to show risky driving behaviors, even when brain damage was present (evidence of white matter damage caused by reduced ...

Data analysis finds multiple antiplatelets linked to worse outcomes after a brain bleed

2026-01-29
Research Highlights: Based on an analysis of a decade of hospital stroke registry data, people who had brain bleeds were more likely to die in the hospital if they were taking multiple antiplatelet medications, or medications stronger than aspirin, before the bleed. People who were taking only aspirin before the brain bleed had the same risk of death as those not taking any antiplatelet medications. The results open the door to research on how to improve care for people hospitalized with a brain bleed who have been taking antiplatelet medications. Note: The study featured in this news release is a research abstract. Abstracts presented at the American Heart Association/American ...

Tear in inner lining of neck artery may not raise stroke risk in first 6 months of diagnosis

2026-01-29
Research Highlights: Adults who had a dissecting aneurysm in the neck artery wall (a cervical artery dissection or CeAD) did not have a higher risk of stroke compared to those with cervical artery dissection without a dissecting aneurysm in the first six months after diagnosis, according to data analysis from a global registry. The findings should offer reassurance and much-needed information about how best to diagnose and treat people with dissecting aneurysm and CeAD, researchers said. Note: The study ...

New risk assessment tool may help predict dementia after a stroke

2026-01-29
Research Highlights: A new risk prediction tool was able to accurately identify stroke survivors with the highest risk for developing dementia within a decade of having a stroke, according to a large study in Canada. Factors linked with a higher risk of developing dementia after a stroke included being older, having any disability before the stroke, having a higher level of disability after the stroke, having an intracerebral hemorrhage (compared to an ischemic stroke), having diabetes, experiencing cognitive symptoms during hospitalization ...

LAST 30 PRESS RELEASES:

Instead of tracking wolves to prey, ravens remember — and revisit — common kill sites

Ravens don’t follow wolves to dinner – they remember where the food is

Mapping the lifelong behavior of killifish reveals an architecture of vertebrate aging

Designing for hard and brittle lithium needles may lead to safer batteries

Inside the brains of seals and sea lions with complex vocal behavior learning

Watching a lifetime in motion reveals the architecture of aging

Rapid evolution can ‘rescue’ species from climate change

Molecular garbage on tumors makes easy target for antibody drugs

New strategy intercepts pancreatic cancer by eliminating microscopic lesions before they become cancer

Embryogenesis in 4D: a developmental atlas for genes and cells

CNIO research links fertility with immune cells in the brain

Why do lithium-ion batteries fail? Scientists find clues in microscopic metal 'thorns'

Surface treatment of wood may keep harmful bacteria at bay

Carsten Bönnemann, MD, joins St. Jude to expand research on pediatric catastrophic neurological disorders

Women use professional and social networks to push past the glass ceiling

Trial finds vitamin D supplements don’t reduce covid severity but could reduce long COVID risk

Personalized support program improves smoking cessation for cervical cancer survivors

Adverse childhood experiences and treatment-resistant depression

Psilocybin trends in states that decriminalized use

New data signals high demand in aesthetic surgery in southern, rural U.S. despite access issues

$3.4 million grant to improve weight-management programs

Higher burnout rates among physicians who treat sickle cell disease

Wetlands in Brazil’s Cerrado are carbon-storage powerhouses

Brain diseases: certain neurons are especially susceptible to ALS and FTD

Father’s tobacco use may raise children’s diabetes risk

Structured exercise programs may help combat “chemo brain” according to new study in JNCCN

The ‘croak’ conundrum: Parasites complicate love signals in frogs

Global trends in the integration of traditional and modern medicine: challenges and opportunities

Medicinal plants with anti-entamoeba histolytica activity: phytochemistry, efficacy, and clinical potential

What a releaf: Tomatoes, carrots and lettuce store pharmaceutical byproducts in their leaves

[Press-News.org] Traditional and novel virologic markers for functional cure and HBeAg loss with pegylated interferon in chronic hepatitis B